The stakeholders for this particular research project are quite widespread. The nursing community and the community as a whole have been affected by diabetes and the side effects and complications of diabetes; determining the best methods for dealing with the problems associated with diabetes has become incredibly important (ACCORD Study Group, 2010). Stakeholders are, of course, individuals who are highly at risk for the disease; however, medical professionals are also affected by the outcome of the study and will benefit from the experience gleaned by the researchers (Dixon et al., 2008; Gæde et al., 2008; Sigal et al., 2006).
Because the stakeholders are so widely spread with such diverse interests, it is important for the organization to recognize each of these interests independently and act on them accordingly. Once the research has been completed, each set of stakeholders should be allowed access to the research insofar as it is possible to allow them access; education for individuals most likely to become ill, for instance, is much more likely to stave off disease and the development of diabetes than allowing people to continue on the course that has caused them so many problems.
Once the research has been completed, the nursing community as a whole must be made aware of any issues or conclusions that have been drawn from the study, especially as they pertain to existing strategies for dealing with diabetes, like fenofibrate therapy and diet change (Holman et al., 2008). Current research suggests that diet and lifestyle changes can be significant for individuals at high risk for diabetes and even for individuals with diabetes, but determining how best to implement those changes can be difficult for medical staff (Salas-Salvadó et al., 2011; Lindström et al., 2006).
Although it is common knowledge that diabetes and obesity are easily treatable through diet and lifestyle changes, it is important to note that making diet and exercise changes is quite difficult for most people— most people do not have the skill set necessary to change their entire lives without serious intervention and assistance, and many locations do not have the social structures necessary to provide this type of assistance to individuals with type II diabetes or obesity related problems.
Conducting a study and publishing the study is the first step to disseminating information to the nursing community as a whole, but if the program is immensely successful, nursing community outreach in the form of hands-on training might be even more effective and helpful for the community in the long term. When disseminating the information from the study, some attention should also be paid to communicating with general care practitioners so that the major problems associated with obesity and pre-diabetic conditions can be avoided in the general population.
The nursing community that is interested in providing successful intervention for individuals with type II diabetes should be aware that there are often problems associated with providing these interventions successfully. The purpose of this research is to determine the best ways to deal with these issues associated with staving off type II diabetes— and the best ways to send the disease into remission as much as possible. There are many options available to these practitioners, including the use of medication and invasive surgery— but it is fundamental to explore other, less invasive options before engaging in any kind of truly life-altering medical course of treatment.
References
1) ACCORD Study Group. (2010). Effects of intensive blood-pressure control in type 2 diabetes mellitus. The New England journal of medicine, 362(17), 1575.
2) Dixon, J. B., O’Brien, P. E., Playfair, J., Chapman, L., Schachter, L. M., Skinner, S., & Anderson, M. (2008). Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. Jama,299(3), 316-323.
3) FIELD Study Investigators. (2005). Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. The Lancet, 366(9500), 1849-1861.
4) Gæde, P., Lund-Andersen, H., Parving, H. H., & Pedersen, O. (2008). Effect of a multifactorial intervention on mortality in type 2 diabetes. New England Journal of Medicine, 358(6), 580-591.
5) Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008). 10-year follow-up of intensive glucose control in type 2 diabetes. New England Journal of Medicine, 359(15), 1577-1589.
6) Kosaka, K., Noda, M., & Kuzuya, T. (2005). Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes research and clinical practice, 67(2), 152-162.
7) Laaksonen, D. E., Lindström, J., Lakka, T. A., Eriksson, J. G., Niskanen, L., Wikström, K., & Ilanne-Parikka, P. (2005). Physical activity in the prevention of type 2 diabetes the Finnish Diabetes Prevention Study.Diabetes, 54(1), 158-165.
8) Lindström, J., Ilanne-Parikka, P., Peltonen, M., Aunola, S., Eriksson, J. G., Hemiö, K., & Louheranta, A. (2006). Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. The Lancet, 368(9548), 1673-1679.
9) Look AHEAD Research Group. (2013). Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. The New England journal of medicine, 369(2), 145.
10) Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2009). Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Diabetologia, 52(1), 17-30.
11) Salas-Salvadó, J., Bulló, M., Babio, N., Martínez-González, M. Á., Ibarrola-Jurado, N., Basora, J., & Ruiz-Gutiérrez, V. (2011). Reduction in the Incidence of Type 2 Diabetes With the Mediterranean Diet Results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes care,34(1), 14-19.
12) Shojania, K. G., Ranji, S. R., McDonald, K. M., Grimshaw, J. M., Sundaram, V., Rushakoff, R. J., & Owens, D. K. (2006). Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. Jama, 296(4), 427-440.
13) Sigal, R. J., Kenny, G. P., Wasserman, D. H., Castaneda-Sceppa, C., & White, R. D. (2006). Physical activity/exercise and Type 2 diabetes A consensus statement from the American Diabetes Association. Diabetes care, 29(6), 1433-1438.
14) Stumvoll, M., Goldstein, B. J., & van Haeften, T. W. (2005). Type 2 diabetes: principles of pathogenesis and therapy. The Lancet, 365(9467), 1333-1346.
15) Yoon, K. H., Lee, J. H., Kim, J. W., Cho, J. H., Choi, Y. H., Ko, S. H., & Son, H. Y. (2006). Epidemic obesity and type 2 diabetes in Asia. The Lancet,368(9548), 1681-1688.
